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ABSTRACT A TL+ leukemia of a (B6 x A)F1 hybrid
mouse (H-2b/JHr2a) was previously subjected to immunoselec-
tion against H-23 by passage in (B6 x A.SW)Fj mice (H-2b/H-
2s). A variant leukemia line was obtained that serologically
lacked not only the H-2a phenotype but also the TL phenotype
determined by the linked cis Tlaa allele of strain A. The H-2b
phenotype and the TL phenotype of the Tlab allele of the B6
strain, which is expressed only by leukemia cells, were retained
by the variant. Southern blotting with an H-2 cDNA probe that
identifies restriction fragment polymorphisms distinguisiing
alleles of the H-2 and Tla regions of the B6 and A strains
indicates that both the H-2a and Tla? alleles are missing from
the genome of this H-2a:Tlaa negative variant. Since the vari-
ant has two apparently unaltered chromosomes 17, where the
H-2:Tla complex is situated, and sihce the intensity of bands in
Southern blotting is suggestive of H-2b homozygosity, it is
considered that loss of the H-2a:Tlaa hhplotype by the variant
was accompanied by duplication of the H-2b:Tlab haplotype.
The implied change from heterozygosity to homozygosity that
the variant has undergone with respect to H-2:Tla was not
paralleled by a similar change at the three other loci tested,
since the variant retained heterozygosity for Pep-3 (chromo-
some 1), Gpi-l (chromosome 7), and Es-i (chromosome 8).
When H-2 heterozygous tumor ceJls of the mouse are sub-
jected to immunoselection against the products of one of
their H-2 phenotypes, variant cell lines are obtained that lack
that H-2 phenotype (reviewed in ref. 1).
As a means to understanding the relation of leukemia to
the Tla locus, which exhibits abnormal expression in TL+
leukemia cells of TL- mouse strains like C57BL/6 (B6), a
variadt of this kind was previously selected from a TL + (B6
x A)F1 hybrid leukemia (H-2b/H-2a) by passage in (B6 x
A.SW) recipients (H-2b/H-2s) and was found to have lost not
only the serological H-2a phenotype but also the TL phe-
notype determined by the linked (cis) Tlaa allele (2). The
serological phenotypes for H-2b, and Tlab were retained. It
has now been possible to study this phenotypically negative
variant further to determine whether it has undergone ge-
nomic loss of the H-2 and Tia regions of the H-2a: Tlaa
haplotype.
MATERIALS AND METHODS
Preparation of the Probe. Probe Ila (3) was isolated from
the pH-211a clone by digestion with Pst I and Pvu II or with
ftha I and Sac I, followed by self-ligation with T4 ligase. The
probe was nick-translated to a specific activity of 2 x 108
cpm/,ug with [a-32PJdNTP.
Preparation of DNA. High molecular weight DNA was
prepared from normal thymocytes and spleen cells combined
or from leukemia cells according to Blin and Stafford (4),
Table 1. Phenotypes
Cell
(B6 x A)F1 (B6 X A)FI leukemia
Phenotype thymocyte Unselected Variant
H-2a + +
H 2b + + +
TL.1 + + +
TL.2 + + +
TL.3 + +
TL.4 - + +
The variant was selected by passage in (B6 x A.SW)F1 hybrids
(2).
except that the cells were not frozen and that two further
extractions with chloroform/isoamylalcohol (24:1) were per-
formed after phenol extraction.
DNA Blot Hybridization. DNA was completely digested
with restriction enzynie EcoRI; BamHI, 6rBgl II, subjected
to electrophoresis on 6-mm thick 0.7% agarose gels in TAE
buffer (40 mM Tris acetate/2 mM EDTA' pH 8.0), and
transferred to nitrocellulose filters. The bldts were baked and
hybridized with 32P-labeled pH-211a probe as described (5).
Phenotypes of the Unselected and Variant Leukemia Lines.
This information is given in Table 1. The unselected and
variant leukemia lines were carried in passage in ascites form
in (B6 x A)Fi hybrids or in culture if so indicated.
Cytogenetics. Cytogenetic studies were performed on ac-
tively proliferating cultures of the. unselected and variant
leukemia cell lines. Colcemid (0.05 ,g/ml) was added to
cultures 1 hour before harvest. Chromosome preparations
were made by conventional methods using 0.075 M potas-
sium chloride as the hyposmotic solution and 3:1
methanol/acetic acid as the fixative. Q-banding was used in
the analysis of karyotypes (6).
RESULTS
Southern Blotting with the pH-2IIa Probe. The pH-211a
probe was hybridized with EcoRI restriction fragments (RFs)
of DNA from cells of the unselected and H-2a:Tlaa negative
variant leukemia lines. The RF patterns are shown in Fig. 1
in comparison with cells of the B6 (H-2b:Tlab) and A (H-
2a: Tlaa) parental inbred strains and of the B6-Tlaa and A-Tlab
recombinant congeneic strains. Use of B6-Tlaa and A-Tlab
congeneic cells (7, 8) permits assignment of RF polyniorph-
isms to the H-2:Qa-2,3 and telomeric TIa regions. The RF
patterns of unselected (B6 x A)F1 leukemia cells and of
normal ($6 x A)F1 cells were not distinguishable from one
another and composed a combination ofRFs of the B6 and A
parental inbred strains. The RF pattern of the H-2a:Tlaa
Abbreviation: RF, restriction fragment.
§Typed by Harold A. Hoffman of Animal Genetic Systems (11 Taft
Court, Rockville, MD 20850).
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FIG. 1. Southern blots of EcoRI restriction fragments (shown in kilobases) hybridized with the pH-211a probe, showing one of several
exposure times needed (A) to visualize both faint and strong polymorphic fragments, and key diagram (B). The quantity of DNA digested
with 10 ug for all cells except those of the unselected leukemia (lane 5) and (B6 x A)F1 normal cells (lane 6), for which 20 gg was used,
provides equal material for showing RF polymorphisms. The point of recombination for the B6-Tlaa haplotype is between Qa-2,3 and Tla (7,
8). Similar results were obtained with BamHI and Bgl II.
negative variant, on the other hand, was indistinguishable
from that of B6 normal cells and of B6 leukemia cells. The
patterns were not affected by increase in the concentration of
restrictionterezyme. Accordingly, four polymiorphic RFs ofA
strain origin are missing front the variant, and another of B6
(Tia region) origin is retained. The intensity of this B6 band
from the variant cells was similar to B6 (TIab) and A.Tlab
cells for equal input of DNA and to twice the amount of (B6
x A)F1 pNA, suggesting that the variant cells are now
homozygous in the Tla region.
Results similar to those -described above were obtained
with BamHI and Bgl II, both of which, like EcoRI, identify
RF polymorphisms in both the H.:2:Qa-2;3 and Tla regions.
Biochemical Phenotypes§. Pep-3 (Chromosome 1), Gpi-1
(chromosbme 7), and Es-1 (chromosome 8) are three bio-
chemical markers for which the B6 and A strains differ and
which were expressed in the leukemia cells. For all three
markers, the dnselected and variant lines displayed the phe-
notype of hetetozygotes. DNA from host cells contaminating
the washed ascites leukemia cells used for these tests can be
discounted because such contaminant cells are very scarce
and because the intensity of reaction was the same for the
unselected and variant cell lines.
Cytogenetics. Q-banded chromosomes were examined from
50 metaphase spreads, each from the unselected and the
variant preparations (Fig. 2). The unselected cells exhibited
a modal chromosome number of 40 (45 cells) and a normal
male karyotype (40, XY). Both chromosomes 17 exhibited a
normal banding pattern. One hypodiploid cell (33 chromo-
somes) and 1 hyperdiploid cell (60 chromosomes) were pre-
sumed to be technical artefacts. A long acrocentric chromo-
some (mar 1) was present in 2 cells (41. chromosomes),
whereas the final cell, which had mar 1, also had an addi-
tional tiny acrocentric chromosome (mar 2). The latter 3 cells
therefore belong to a clone, making the population a mosaic
FIG. 2. Q-banded karyotype of a presumed H-2b:Tiab homozy-
gous cell of the variant line showing the two marker chromosomes.
The karyotype otherwise is normal. (x1300.)
- Tla region
H 2 Oa-2 3
_ H-2 Qa-2.3
-iTa region
-TIa region
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one. The mar 1 chromosome comprised a tandem duplication
of chromosome 12 with the segment 12B -* ter attached to
another chromosome 12 at band F2. The banding pattern of
mar 2 was compatible with that of the segment 12cen -* 12B.
Since each of these cells also had 2 normal chromosomes 12,
the markers probably were derived through an inter-chro-
matid exchange between the 2 chromosomes 12 followed by
non-disjunction in the progenitor cell. Loss of mar 2, prob-
ably again by non-disjunction, resulted in the clone with 41
chromosomes. Thus, the cells with 42 chromosomes are
tetrasomic for the entire chromosome 12, whereas those with
41 chromosomes are tetrasomic for the region i21 -* F and
disomic for the regions 12cen -* 12B and 12F -- ter. Of the
50 variant cells studied, 11 had 42 chromosomes, each with
mar 1 and mar 2, whereas the remaining 39 had 41 chromo-
somes, each with mar 1 alone. The karyotype of these cells,
including both chromosomes 17, was otherwise normal.
Therefore, the selection applied must have fixed a 42-chro-
mosome cell with mar 1 and mar 2, which also became
homozygous at the H-2:Tla region as the progenitor of the
variant. The unstable mar 2 was lost in the majority of
unselected as well as variant cell populations.
DISCUSSION
A feature of special interest concerning H-2:Tla loss vari-
ants, Which prompted investigation of TL phenotypic losses
by H-2-selected variants in the first place (2), is the possible
relation of Tla genes to malignant transformation. The main
point is that TL antigens are expressed not only by T-cell
leukemias of mice whose thymocytes express TL constitu-
tively (Tlaa; e.g., strain A) but also by T-cell leukemias of
TL-null mice whose thymocytes do not express TL (Tlab;
e.g., strain B6)-hence, the choice of a (B6 x A)F1 leuke-
mia, which expresses both constitutive (Tlaa) and irregular
(Tlab) TL antigens, in determining whether retention of par-
ticular Tla alleles is required for the proliferative behavior of
TL+ leukemias. We now see that this is not so for the
constitutive Tlaa allele of the leukemia in question.
Whatever genomic abnormality there may be in the Tlab
locus retained by the variant, which exhibits abnormal
expression in leukemia cells, it was not revealed in the
present study since the RF banding pattern of the unselected
leukemia cells did not demonstrably differ from that of nor-
mal (B6 x A)F1 cells nor did the RF patterns of the variant
cells and of TL+ and TL- B6 leukemia cells demonstrably
differ from that of normal B6 cells.
A reciprocal (H-2b:Tlab negative) variaht was previously
selected from the same leukemia by passage in (A x B6-H-
2k)F1 recipients (H-2a/H-2k) and its proliferative capacity
also was not changed (9). Unfortunately, this variant did not
survive frozen storage, and it is unsafe to assume that it also
arose by genomic loss of an H-2:Tla haplotype. Immuno-
selection for loss of both H-2 haplotypes has never suc-
ceeded with tumors of any kind [loss due to a ,2M mutation
is another matter since this does not involve genomic loss of
H-2 (10, 11)] and the question remains whether a change at
both Tia loci may be obligatory in leukemic cellular prolif-
eratioh.
With regard to mechanisms of variant formatiof, there is
no reason to suppose that they are peculiar to transformed
cells, though much more difficult to study in normal somatic
cells. Somatic segregation and mitotic recombination were
originally favored in the case of H-2 loss variants because it
was often possible to select partial loss variants ofH-2K :H-
2D+ type with respect to one haplotype but rarely or never
the H-2K+:Il-2D- type ("polarity") (1). This mechanism
seemed to be ruled out when it was later found that the
centromerb of chromosome 17 lies on the K rather than the
D side of H-2, but Susumu Ohno (personal communication)
points out that somatic recombination accompanied by re-
duction and subsequent duplication ofchromosome 17 would
give the K-D polarity actually observed.
More generally, likely cyto'enetic mechanisms that can
account for the formation of variants of the sort in question
are the following: (i) hemizygosity, attained either by de-
letion of a chromosome segment or by chromosome loss
from non-disjunction, and (ii) homozygosity, attained by
point mutation, chromosome loss by non-disjunction fol-
lowed by duplication of thd remaining chromosome by a
second non-disjunction, or mitotic recombination. Monos-
omy is relatively common in human leukemia cells (12);
indeed, in a subset of acute lymphoblastic leukemia the
entire autosomal complement may become monosomic, giv-
ing rise to near-haploid genomes (13, 14). Cytological evi-
dence for mitotic recombination in human lymphoid and
other cells has been presented by several investigators dur-
ing the past 20 years (15-18). In retinoblastoma, a childhood
intra-ocular tumor with a predisposing gene on chromosome
13 (Rb-i), a recent comparison of constitutional and tumor
genotypes at a number of chromosome 13 loci (esterase-D, a
gene closely linked to Rb-I and several RF length polymor-
phisms related to arbitrary loci) showed that tumorigenesis is
associated with hemizygosity attained by non-disjunctional
loss of the chromosome carrying the wild-type allele or
homozygosity attained either by duplication of the chromo-
some carrying the mutant allele in a hemizygous cell or by
mitotic recombination of Rb-i (19, 20). An identical situation
has just been reported at several loci on chromosome 11p
(restriction length fragment polymorphisms flanking the
genes for parathyroid hormone, 3-globin, insulin, and c-Ha-
ras-1) when constitutional genotypes were compared with
tumor genotypes in a number of patients with Wilms tumor,
a-childhood kidney tumor with a predisposing locus on 11p
(21-24).
In the present study, analysis of both restriction enzyme
fragments and chromosomes indicated that loss of the H-
2a: Tlaa haplotype by the variant was accompanied by du-
plication of the H-2b: Tiab haplotype. Rajan et al. (25) re-
cently isolated H-2" and H-2d loss variants from an H-2b/
H-2d heterozygous Friend leukemia cell line L3y immuno-
selection with antisera against the respective haplotypes.
Their studies of restriction enzyme fragments and alleles at
the H-2-linked locus Glyoxylase-I (Glo-i) also implied at-
tainment of homozygosity for the remainlhg H-2 type fol-
lowing selection. Those results and ours are consistent with
an origin of homozygosity by mitotic recombination, al-
though formally neither set of data permits distinction be-
tween non-disjunctional loss of a chromosome followed by
duplication of its homologue and mitotic recombination.
Certainly the length of chromosome rendered homozygous
can extend from unselected loci on the centromeric side of
H-2 (Glo-i) to unselected loci on the telomeric side (Tia).
Thus, loci to which no selection pressure has been applied
may be rendered homozygous if they are linked to the
immunoselected H-2 complex.
Events at other heterozygous loci that are not H-2 linked
are of interest because they bear on the question of whether
the variant-producing mechanism affected only chromosome
17 or the genome as a whole. For instance, if all chromosome
pairs were involved, as in meiotic segregation and recombi-
nation, then there is a 50% chance of homozygosity at any
originally heterozygous locus not linked with H-2 and situ-
ated 50 centimorgans or more from the centromere of that
chromosome. For loci nearer the centfomere the chance
would be proportionally higher. The fact that the three loci,
Pep-3, Gpi-i, and Es-i (chromosomes 1, 7, and 8), remained
heterozygous in the variant would suggest that the event that
produces an ?-2:Tia homozygous variant in the circum-
stances described characteristically afftcts a single chromo-
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some pair-in this case, chromosome 17-particularly since
Gpi-J is probably <15 centimorgans from its centromere.
The marker chromosomes observed are of interest in an-
other context. The distal breakpoint in mar 1 is in band 12F2
at which chromosome 12 also rearranges in one of the two
consistent translocations reported in Pristine-induced plas-
inacytomas in BALB/c mice-namely, t(12;15)(F2;D3) (26).
In this translocation, the cellular oncogene myc, normally
located on chromosome 15, is translocated into the immu-
noglobulin heavy chain (IgH) locus, whose position previ-
ously has been determined to be distal to band 12F1 (27). The
rearranged c-myc has been shown to undergo activation (28).
A parallel translocation of human c-myc, normally located at
8q24 (29) to the IgH locus, at 14q32 (30) has also been shown
to lead to c-myc activation in Burkitt lymphoma (31, 32). In
the human autosomal recessive disorder ataxia-telangiecta-
sia (A-T), a primary immunodeficiency that strongly pre-
disposes to lymphoid neoplasia, a translocation occurring in
the T lymphocytes of a number of patients involves the 2
chromosomes 14 with breaks in a proximal (q12) and a distal
band (14q23) (33); the latter, as noted above, is in the region
IgH. A-T lymphocytes with the 14-14 translocation exhibit
proliferative advantage and eventually become the only rec-
ognizable T cells in the peripheral circulation (34). Possibly
the rearrangement causes activation of a T-cell proliferation-
related gene normally situated at 14q12. As with the 14-14
translocation in A-T, the 12-12 translocation observed in the
H-2a loss variant also may transpose a proximal gene into the
distal IgH locus on chromosome 12. The significance of this
rearrangement in the evolution of the class of leukemias
represented in the present study remains to be determined.
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